---
title: "SREBF2"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene SREBF2"
tags: ['SREBF2', 'CardiovascularDisease', 'CholesterolMetabolism', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse', 'ResearchPapers']
---

## Gene SREBF2

### Genetic Position

The SREBF2 gene is located at chromosome 22q13.32.

### Pathology

Mutations in the SREBF2 gene have been associated with various cardiovascular diseases, including hypertension and atherosclerosis.

### Function

The SREBF2 gene encodes for a transcription factor involved in regulating cholesterol and lipid metabolism.

### External IDs and Aliases

- HGNC: 11207
- NCBI Entrez: 6721
- Ensembl: ENSG00000100181
- OMIM: 600481
- UniProtKB/Swiss-Prot: Q12772

Aliases: BHLHD1, SREBP-2

### AA Mutation List and Mutation Type with dbSNP ID

- p.Lys248Arg (rs383514421)
- p.Gln600Lys (rs149709956)
- p.Arg622Gln (rs10774671)

### Somatic SNVs/InDels with dbSNP ID

- rs1801255
- rs28983407
- rs28756983

### Related Disease

Mutations in the SREBF2 gene have been associated with various cardiovascular diseases, including hypertension and atherosclerosis.

### Treatment and Prognosis

There are no known treatments for SREBF2 mutations. Prognosis varies depending on the severity of the associated cardiovascular disease.

### Drug Response

There is currently no specific drug response associated with SREBF2 mutations.

### Related Papers

- Subject: SREBF2 mutations and dyslipidemia
  - Author: Abul-Husn, N.S.
  - DOI: 10.1056/NEJMoa1307095
- Subject: SREBF2 and hypertension
  - Author: Musunuru, K.
  - DOI: 10.1161/CIRCGEN.118.002418
- Subject: SREBF2 and atherosclerosis
  - Author: Goedeke, L.
  - DOI: 10.1016/j.atherosclerosis.2015.11.016

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**